Corpus ID: 26290798

Real-life costs of hepatitis C treatment.

@article{Helsper2012ReallifeCO,
  title={Real-life costs of hepatitis C treatment.},
  author={Charles Helsper and H L Hellinga and Gerrit A van Essen and G. Ardine de Wit and Marc J. M. Bonten and Karel Johannes van Erpecum and Andy I. M. Hoepelman and Christian Richter and Niek J de Wit},
  journal={The Netherlands journal of medicine},
  year={2012},
  volume={70 3},
  pages={
          145-53
        }
}
  • Charles Helsper, H L Hellinga, +6 authors Niek J de Wit
  • Published in
    The Netherlands journal of…
    2012
  • Medicine
  • BACKGROUND Hepatitis C virus infection is a serious health threat in today's society. Improved identification strategies have increased the number of patients undergoing the expensive treatment with ribavirin and peg-interferon, inducing a substantial economic burden. METHODS In a retrospective cohort study in three treatment centres in the Netherlands, files of patients treated between 2001 and 2010 were systematically searched for all cost-inducing treatment details. Costs of treatment… CONTINUE READING

    Create an AI-powered research feed to stay up to date with new papers like this posted to ArXiv

    Citations

    Publications citing this paper.
    SHOWING 1-10 OF 11 CITATIONS

    12 Years of Universal Access to Hepatitis C Treatment

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 16 REFERENCES

    Genotype distribution amongst hepatitis C patients in The Netherlands.

    VIEW 7 EXCERPTS
    HIGHLY INFLUENTIAL